Meanwhile, overexpression of ErbB1 has been correlated with gastric cancer, human hepatocellular carcinoma, and oesophageal cancer [19], and ErbB3 has been implicated in breast, bladder, and gastric cancers [13], whereas ErbB4 is also commonly associated with gastrointestinal cancer [20]. This evidence concerns the gene ERBB4 and gastric cancer.